Boothbay Fund Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Boothbay Fund Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-103,700	Closed	-$1.77M	–	2392
2021 Q3	$1.77M	Sell	103,700 -4,900	-5%	-$76.3K	0.05%	499
2021 Q2	$1.45M	Buy	108,600 +108,030	+18,953%	+$2.66M	0.05%	529
2021 Q1	$2.92M	Buy	570 +100	+21%	+$6.02K	0.11%	214
2020 Q4	$2.91M	Buy	+470	New	+$26.9K	0.11%	184
2020 Q3	–	Sell	-632	Closed	-$3.64M	–	1310
2020 Q2	$3.64M	Buy	+632	New	+$34.4K	0.25%	92

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Boothbay Fund Management's CCXI Position: Q3 2021 in Review

Boothbay Fund Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 53,528 shares — an estimated $834K sold.

Boothbay Fund Management first reported a position in CCXI in Q4 2016 and held it in 4 quarters. The position peaked at $717K in Q2 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

Boothbay Fund Management reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
Boothbay Fund Management sold 53,528 ChemoCentryx, Inc. shares in Q3 2021, an estimated $834K.
Boothbay Fund Management first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 4 quarters.
Boothbay Fund Management's ChemoCentryx, Inc. position peaked at $717K in Q2 2021.
140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.